吡唑并[1,5-α]吡啶类化合物的合成及其体外受体结合分析

doi:10.3724/SP.J.1095.2014.30428

摘要/Abstract

摘要： 以吡唑并[1,5-α]吡啶-3-甲醛和N-甲酰基哌嗪为原料，经过还原胺化、水解和N-烷基化反应，合成了3-(4-苄基哌嗪-1-基甲基)吡唑并[1,5-α]吡啶、3-[4-(4-氯苄基)哌嗪-1-基甲基]吡唑并[1,5-α]吡啶和3-[4-(4-甲氧基苄基)哌嗪-1-基甲基]吡唑并[1,5-α]吡啶，通过1H NMR、ESI MS等技术手段对中间体及3个目标化合物进行了表征，并通过体外受体结合实验，测定3个目标化合物对多巴胺D4.2受体的亲和常数(Ki)分别为1.6、7.2、65 nmol/L；对D2受体的亲和常数分别为1920、5320和9800 nmol/L；对D3受体的亲和常数分别为1710、4270和5600 nmol/L。结果表明，3-(4-苄基哌嗪-1-基甲基)吡唑并[1,5-α]吡啶对多巴胺D4受体具有较高的亲和性与选择性，是多巴胺D4受体潜在的配基。

关键词: 吡唑并[1,5-&, alpha, ]吡啶, 多巴胺D4受体, 配基, 体外受体结合分析

Abstract: 3-(4-Benzylpiperazin-1-ylmethyl)pyrazolo[1,5-α]pyridine, 3-[4-(4-chlorobenzyl) piperazin-1-ylmethyl]pyrazolo-[1,5-α]pyridine and 3-[4-(4-methoxybenzyl)piperazin-1-ylmethyl] pyrazolo[1,5-a]pyridine were synthesized from pyrazolo[1,5-α]pyridine-3-carbaldehyde and 1-piperazinearboxaldehyde through reductive amination, amide hydrolysis and N-alkylation. The structures of the intermediates and the target compounds were confirmed by 1H NMR and ESI MS. Through in vitro receptor binding assay, the affinity constants(Ki) of the target compounds were determined to be 1.6, 7.2, 65 nmol/L for D4 receptor; 1920, 5320, 9800 nmol/L for D2 receptor; 1710, 4270 and 5600 nmol/L for dopamine D3 receptor, respectively. The results suggested that 3-(4-benzylpiperazin-1-ylmethyl)pyrazolo[1,5-α] pyridine is a potential dopamine D4 receptor ligand.

Key words: pyrazolo[1,5-&, alpha, ]pyridine, dopamine D4 receptor, ligand, in vitro receptor binding assay

中图分类号:

O626

李谷才, 孙磊, 陈波, 钟怀玉. 吡唑并[1,5-α]吡啶类化合物的合成及其体外受体结合分析[J]. 应用化学, DOI: 10.3724/SP.J.1095.2014.30428.

LI Gucai*, SUN Lei, CHEN Bo, ZHONG Huaiyu. Synthesis and in vitro Receptor Binding Assay of Pyrazolo[1,5-α]pyridines[J]. Chinese Journal of Applied Chemistry, DOI: 10.3724/SP.J.1095.2014.30428.

参考文献

[1] YU Lin,CAO Aihua,LV Xiaona,et al. Effect of Dopamine D4 Receptor Agonist ABT-724 on Behaviors in Rat Model of Attention-deficit Hyperactivity Disorder[J]. Chinese J Behav Med Brain Sci,2011,20(9):800-802(in Chinese).

于林,曹爱华,吕孝娜,等. 多巴胺D4受体激动剂ABT-724对注意缺陷多动障碍模型大鼠行为的影响[J]. 中华行为医学与脑科学杂志,2011,20(9):800-802.

[2] Pawel Z,Krzysztof M,Andrzej M,et al. Quinoline- and Isoquinoline-sulfonamide Derivatives of LCAP as Potent CNS Multi-receptor-5-HT1A/5-HT2A/5-HT7 and D2/D3/D4-Agents:the Synthesis and Pharmacological Evaluation[J]. Bioorg Med Chem,2012,20:1545-1556.

[3] Takami G,Ota M,Nakashima A,et al. Effects of Atypical Antipsychotics and Haloperidol on PC12 Cells:Only Aripiprazole Phosphorylates AMP-activated Protein Kinase[J]. J Neural Transm,2010,117(10):1139-1153.

[4] Rostom S A. Novel Fused Pyrrole Heterocyclic Ring Systems as Structure Analogs of LE 300:Synthesis and Pharmacological Evaluation as Serotonin 5-HT2A,Dopamine and Histamine H1 Receptor Ligands[J]. Arch Pharm,2010,343(2):73-80.

[5] JI Weidong,ZHOU Jiaxiu,YANG Chuang,et al. The Executive Function in Han Chinese Children with Tourette′s Syndrome and Its Association with the Polymorphism of DRD4 Exon Ⅲ 48bp VNTR[J]. Chinese Ment Health J,2010,24(8):568-573(in Chinese).

季卫东,周家秀,杨闯,等. 抽动秽语综合征汉族患者的执行功能及与多巴胺D4受体第3外显子48bp可重复序列多态性[J]. 中国心理卫生杂志,2010,24(8):568-573.

[6] Lauzon N M,Laviolette S R. Dopamine D4-receptor Modulation of Cortical Neuronal Network Activity and Emotional Processing:Implications for Neuropsychiatric Disorders[J]. Behav Brain Res,2010,208(1):12-22.

[7] Stefan L,Harald H,Peter G. Synthesis and Biological Investigations of Dopaminergic Partial Agonists Preferentially Recognizing the D4 Receptor Subtype[J]. Bioorg Med Chem Lett,2006,16(11):2955-2959.

[8] Iris R,Gottfried S. Dopamine D4 Receptor Exon Ⅲ Polymorphism, Adverse Life Events and Personality Traits in a Nonclinical German Adult Sample[J]. Neuropsycholoiology,2011,63(1):52-58.

[9] Linz S,M ller J,H bner H,et al. Design, Synthesis and Dopamine D4 Receptor Binding Activities of New N-Heteroaromatic 5/6-ring Mannich Bases[J]. Bioorg Med Chem,2009,17(13):4448-4458.

[10] Lacivita E,De Giorgio P,Lee IT,et al. Design, Synthesis, Radiolabeling, and in vivo Evaluation of Carbon-11 Labeled N-[2-[4-(3-cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3- methoxybenzamide, a Potential Positron Emission Tomography Tracer for the Dopamine D(4) Receptors[J]. J Med Chem,2010,53(20):7344-7355.

[11] LI Gucai,ZHANG Ru,JIANG,Kaijun. Synthesis and Biological Evaluation of Indolin-2-one Derivatives as Dopamine D4 Receptor Ligands[J]. Chem Reag,2012,34(7):593-596(in Chinese).

李谷才，张儒，蒋开军. 二氢吲哚-2-酮类化合物的合成及其体外活性研究[J]. 化学试剂,2012,34(7):593-596.

[12] Olaf P,Rainer T,Jcarsten H,et al. Synthesis, Radiofluorination, and in Vitro Evaluation of Pyrazolo[1,5-α]pyridine-based Dopamine D4 Receptor Ligands:Discovery of an Inverse Agonist Radioligand for PET[J]. J Med Chem,2008,51:1800-1810.

[1]	张会丽, 李珂, 黄文龙, 王蕊, 胡国强. N-(5-芳苄叉基饶丹宁)左氧氟沙星酰胺的合成及抗肿瘤活性[J]. 应用化学, 2019, 36(8): 897-903.
[2]	惠文萍, 刘德娥, 侯丹, 陈战国. 由α-氰基肉桂酸乙酯/N-溴代苯甲酰胺合成2-噁唑啉衍生物[J]. 应用化学, 2017, 34(7): 757-767.
[3]	田振华, 张昊, 于源华. 基于特异性蛋白Gαa的比浊法检测β-葡聚糖[J]. 应用化学, 2016, 33(6): 727-732.
[4]	李贞操, 陈国勇, 陈朗秋, 申望珍, 季善伟. 烷基-α-D-吡喃葡萄糖苷的合成与性能[J]. 应用化学, 2016, 33(11): 1265-1273.
[5]	张丹丹, 查显宇, 高保娇. 在聚砜侧链合成与键合双齿席夫碱配基及功能化聚砜-Tb(Ⅲ)离子配合物荧光发射性能初探[J]. 应用化学, 2016, 33(1): 53-62.
[6]	李志豪, 唐石, 周栋, 邓佑林, 李玉花, 黎淑华. 铜催化烯烃氰烷基化成环合成含氰吲哚酮[J]. 应用化学, 2015, 32(8): 884-891.
[7]	陈晓娟, 张文俊, 陈建新. α -羟基-α -氨甲酰基酰胺类化合物的合成新方法[J]. 应用化学, 2015, 32(5): 547-551.
[8]	徐迪, 高保娇, 陈萍虹. 侧链键合双齿席夫碱配基的聚苯乙烯的制备与表征及其Eu(Ⅲ)配合物荧光发射性能之初探[J]. 应用化学, 2015, 32(2): 183-191.
[9]	唐雪梅, 范莉, 赵琴, 杨大成. 含磺胺嘧啶结构单元β-氨基酮的合成及其生物活性[J]. 应用化学, 2015, 32(11): 1231-1239.
[10]	姚元勇, 吴兰艳, 舒华, 唐帮成, 薛伟. Bronsted酸催化合成α-氨基膦酸酯[J]. 应用化学, 2014, 31(12): 1428-1433.
[11]	胡铁, 黎继烈, 王烨, 高海丽, 皮少峰, 孙汉洲. 关环反应合成鸢尾酮[J]. 应用化学, 2014, 31(11): 1297-1301.
[12]	丁爱祥, 张贵玉, 陆红波, 杨家祥. 荧光液晶分子α-氰基二苯乙烯衍生物的合成与光学性质[J]. 应用化学, 2014, 31(11): 1261-1267.
[13]	李爱元, 施立钦, 孙向东, 王斌, 张慧波. α-蒎烯和间戊二烯共聚工艺[J]. 应用化学, 2014, 31(06): 661-666.
[14]	许泽清, 高保娇, 侯晓东. 键合苯甲酸衍生物聚苯乙烯配体的合成及其Eu(Ⅲ)配合物的光致发光性能[J]. 应用化学, 2014, 31(02): 133-139.
[15]	许立信, 李培杰, 刘巍巍, 徐艳艳, 王知彩. Cr₂O₃/γ-Al₂O₃催化氧化四氢萘合成α-四氢萘酮[J]. 应用化学, 2013, 30(11): 1304-1309.